Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.

However, not all companies with momentum are long-term winners, and many investors have lost money by following short-term trends. All that said, here are three overhyped stocks that may correct and some you should consider instead.

Tri Pointe Homes (TPH)

One-Month Return: +32.3%

Established in 2009 in California, Tri Pointe Homes (NYSE: TPH) is a United States homebuilder recognized for its innovative and sustainable approach to creating premium, life-enhancing homes.

Why Are We Out on TPH?

1. Backlog has dropped by 38.5% on average over the past two years, suggesting it’s losing orders as competition picks up
2. Sales are expected to decline once again over the next 12 months as it continues working through a challenging demand environment
3. Performance over the past two years shows each sale was less profitable as its earnings per share dropped by 7.5% annually, worse than its revenue

Tri Pointe Homes is trading at $46.55 per share, or 17x forward P/E. Dive into our free research report to see why there are better opportunities than TPH.

Exact Sciences (EXAS)

One-Month Return: +0.5%

With a mission to detect cancer earlier when it's more treatable, Exact Sciences (NASDAQ: EXAS) develops and markets cancer screening and diagnostic tests, including its flagship Cologuard stool-based colorectal cancer screening test.

Why Are We Cautious About EXAS?

1. Cash-burning tendencies make us wonder if it can sustainably generate shareholder value
2. Negative returns on capital show that some of its growth strategies have backfired, and its falling returns suggest its earlier profit pools are drying up
3. Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results

At $102.92 per share, Exact Sciences trades at 87.2x forward P/E. If you’re considering EXAS for your portfolio, see our FREE research report to learn more.

Selective Insurance Group (SIGI)

One-Month Return: +5.5%

Founded in 1926 during the early days of automobile insurance, Selective Insurance Group (NASDAQ: SIGI) is a property and casualty insurance company that sells commercial, personal, and excess and surplus lines insurance products through independent agents.

Why Do We Think Twice About SIGI?

1. Earnings growth over the last two years fell short of the peer group average as its EPS only increased by 12.1% annually
2. Capital trends were unexciting over the last five years as its 6% annual book value per share growth was below the typical insurance firm
3. ROE of 11.4% reflects management’s challenges in identifying attractive investment opportunities

Selective Insurance Group’s stock price of $86.42 implies a valuation ratio of 1.4x forward P/B. Read our free research report to see why you should think twice about including SIGI in your portfolio.

Stocks We Like More

The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.